Summary: Neutrophils play a major role in the host defence by producing reactive oxygen species. These products are liberated by activated cells and are known to cause endothelial cell injury and damage. The present study shows that low-density lipoproteins increase Superoxide anion production by twofold in polymorphonuclear leukocytes stimulated by formyl-Met-Leu-Phe in vitro. Moreover, LDL induced a large increase in phosphoinositides and cytosolic-free calcium. Data from experiments performed on neutrophils treated with pertussis toxin, staurosporine, propranolol or nifiumic acid suggest that modulation of phospholipase D and A 2 activities could be involved in the modification by LDL of leukocyte response to formyl-Met-Leu-Phe. LDL lipid moiety could play a key role in their action on polymorphonuclear functions because cholesterol was exchanged between lipoproteins and cells that can modify membrane fluidity and interact with the formyl-Met-Leu-Phe receptor.
Introduction
Dyslipoproteinaemia, demonstrating increased blood lipoprotein concentrations, hypertension and tabagism, is often associated with accelerated atherogenesis mechanisms (1, 2) . Increased lipoprotein concentrations, and especially high low-density lipoprotein (LDL) concentrations, could modify polymorphonuclear leukocyte (PMN) functions. Some authors have reported the enhanced oxidative metabolism of polymorphonuclear neutrophils isolated from hyperlipoproteinaemic subjects and an inhibition of polymorphonuclear neutrophil phagocytosis following their treatment with LDL in vitro (3, 4) .
In a previous study, we demonstrated that LDL stimulates Superoxide (O^") generation by human polymorphonuclear neutrophil in vitro (5) . This effect is concentration dependent and might mediate venous endothelial structure injury by arachidonic acid metabolites, proteolytic enzymes and reactive oxygen species released by activated polymorphonuclear neutrophils (6) (7) (8) (9) (10) . Moreover, they might enhance LDL oxidation and contribute to the formation of foam cells mainly implicated in the atherogenic process (11 -13) .
The oxidative burst results from the assembly and activation of the NADPH oxidase, a transmembrane electron transport chain which reduces oxygen to superoxide (14, 15) . This (Oi~ generation is initiated in neutrophils by a variety of agonists (16) . Among them is the formyl-Methionyl-Leucyl-Phenylalanine, a tripeptide analogous to bacterial wall constituents, and currently being used for in vitro experiments. Polymorphonuclear neutrophil activation by formyl-Met-Leu-Phe triggers a cascade of tightly controlled biochemical events leading to an oxidative burst (17) (18) (19) . The first step consists of the ligand binding to specific cell surface receptors. Among them is the formyl-Met-Leu-Phe receptor which is well-characterized and coupled to cellular responses through a pertussis toxin-inhibitable G protein (20) . Three phospholipases are mainly involved at different steps of neutrophil activation; phospholipase C, phospholipase A 2 and phospholipase D. Hydrolysis of membrane phospholipids leads to the formation of numerous bioactive lipids. These pathways were implicated in the signal transduction of polymorphonuclear neutrophil activated by formyl-Met-Leu-Phe (18, 21) .
In order to clarify LDL effects of formyl-Met-Leu-Pheinduced polymorphonuclear neutrophil oxidative burst, we investigated in vitro the action of pharmacological tools on some steps of transduction leading to the oxidative burst of polymorphonuclear neutrophil.
Materials and Methods

Reagents
Pertussis toxin (lot 72H-0641-1), staurosporine, propranolol, nifiumic acid, and formyl-Met-Leu-Phe were purchased from Sigma Chemical Co. (Saint-Louis MO, USA).
Stock solutions of formyl-Met-Leu-Phe (1 mmol/l) and staurosporine (1 mmol/l) were prepared in dimethyl sulphoxide and stored at -20 °C. Lipoprotein isolation LDL (1.030 < d < 1.050 kg/1) was prepared from the serum of normolipaemic subjects (3.5 mmol/1 < total cholesterol < 6.5 mmol/1 and triacylglyerols < 1.0 mmol/1) in the presence of ethylenediaminetetraacetic acid (2.69 μπιοΐ/ΐ) and phenylmethylsulphonyl fluoride (0.1 mmol/1) to prevent both action of lipolytic enzymes and endogenous proteases and to avoid oxidation. Isolation of LDL was achieved through two successive ultracentrifugation steps at 100 000 g for 18 hours at 4 °C. It was then dialyzed exhaustively against the phosphate buffer and stored for less than five days under nitrogen at 4 °C after sterilization by filtration (0.22 urn Millipore). The purity of the LDL fraction was assayed by SDS polyacrylamide gel electrophoresis. Since the main constituent of LDL is cholesterol, LDL concentration was expressed as LDL cholesterol in mmol/1.
Cell preparation
The cells were isolated from heparinized (10000 U/l) peripheral blood of healthy volunteers from the laboratory population, by successive use of Ficoll-Hypaque and polyvinylalcohol (22) . After isolation, the cells were put in a phosphate buffered solution for determination of Superoxide generation and viability was assessed through a trypan blue exclusion test.
Superoxide production
Superoxide production was measured in terms of ferricytochrome c reduction as previously described (5, 23) . The stimulating agent was formyl-Methionyl-Leucyl-Phenylalanine 100 nmol/1. The results were expressed as O^ release in mmol/10 6 cells.
Phospholipid turnover analysis
Polymorphonuclear neutrophil labelling
After isolation, polymorphonuclear neutrophil cell count was adjusted to 10 10 /1 in Hank's balanced salt solution containing 20 mmol/1 Hepes, pH = 7.4, supplemented with 250 mg/1 bovine serum albumin as previously described (24) . Cells were labelled with 7.4 GBq/1 (200 mCi/1) of Hiyo-[2- At the end of incubation, cells were washed three times, counted and put in the same Hank's solution, supplemented with 1 g/1 bovine serum albumin and 10 mmol/1 LiCl (for inhibiting the enzymes of inositol phosphate dephosphorylation). Cells were adjusted to a concentration of 10 7 cells per 600 μΐ aliquots and incubated for 10 min at 37 °C before the stimulation.
Polymorphonuclear neutrophil stimulation
Stimulating agents were applied to aliquots tested in duplicate, as follows: The reaction was stopped by addition of perchloric acid, followed by three cycles of freezing-thawing.
After centrifugation, the hydrosoluble perchloric acid precipitation supernatants containing inositol phosphates were diluted and neutralized. The inositol lipids were extracted from the perchloric acid insoluble pellets, dried and deacylated by alkaline hydrolysis as described by Creba et al. (25) ]glycerophosphoryl esters were then separated by anion-exchange chromatography on Dowex AG1-X8 columns using the buffer system described by Downes et al. (27) and Berridge et al. (28) .
Cytosolic-free calcium concentrations
Changes in cytosolic free calcium concentration were measured in polymorphonuclear neutrophil loaded with 1 umol/l Fura 2/AM at 37 °C for 45 min (29, 30) . Cells were then washed and suspended in 10 mmol/1 HEPES/Hank's balanced salt solution. Fura 2 fluorescence assays were performed with aliquots of 5 Χ 10 6 polymorphonuclear neutrophil in 2 ml Hank's balanced salt solution, using a fluorimeter (Jobin Yvon 3D, France) equipped with a thermally controlled cuvette holder and a magnetic stirrer. Various concentrations of LDL were tested: 0.01 to 5 mmol/1 cholesterol. Excitation and emission wavelengths for Fura 2 fluorescence assays were 340 and 510 nm, respectively. Cytosolic calcium concentrations were calculated as described (30) .
Intracellular level of polymorphonuclear neutrophil cholesterol
Polymorphonuclear neutrophils were preincubated in duplicate at 37 °C for 5 min and placed in contact with increasing concentrations of LDL for 15 min. Superoxide generation was measured in half of the tubes and cellular cholesterol content was measured in the other. In these tubes, ferricytochrome c was omitted. After stopping the reaction in an ice-water bath, the cells were washed three times in phosphate buffered saline before freezing.
After lipid extraction from neutrophils, cellular cholesterol measurement was performed by gas chromatography coupled with mass spectrometry. This measurement was performed in the Laboratoire de Biochimie des Lipoproteines de Dijon (Service du Pr Gamberf).
Statistical analysis
The Mann-Whitney's test and the Wilcoxon's test were used for the comparison of unpaired and paired quantitative variables.
Results
After polymorphonuclear neutrophil preincubation for 5 min at 37 °C with buffer or LDL, Superoxide production was assayed over the next 5 min in the presence of formyl-Met-Leu-Phe 100 nmol/1. Stimulation of polymorphonuclear neutrophils by formyl-Met-Leu-Phe in the presence of LDL also led to an increase of phosphatidylinositol 4,5-bisphosphate in all the LDL or formyl-Met-Leu-Phe concentrations used (tab. 1).
Effect of LDL on calcium mobilization
The intracellular Ca 2+ mobilization, measured as Fura 2 fluorescence intensity, increased with LDL concentrations ( fig. 2) . At the lowest LDL concentration, the kinetics were similar to those obtained by formyl-MetLeu-Phe stimulation. At LDL concentrations above 0.5 mmol/1 cholesterol, kinetics were the same as those obtained after polymorphonuclear neutrophil stimulation by a particular agent, such as opsonized zymosan. Bovine albumin at concentrations from 0.1 to 1.0 mg/1 induced less than 1/10 of the increase in Fura 2 fluorescence intensity induced by LDL at respective protein concentrations.
Staurosporine effect
At a concentration of 100 nmol/1, Staurosporine showed a potentiation of formyl-Met-Leu-Phe-induced polymer- Propanolol exerted a potent stimulating effect at a concentration of 0.5 mmol/1 but an inhibiting effect at the highest concentration (5 mmol/1).
LDL added their proper effect to that exerted by formylMet-Leu-Phe ( fig. 3a) .
Niflumic acid effect
Niflumic acid had no effect on polymorphonuclear neutrophil stimulation by LDL. When the cells were preincubated for 5 min at 37 °C with various concentrations of niflumic acid (88.6 μηιοΐ/l, 443 μηιοΙ/1, 886 μηιοΙ/1,
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Discussion
This study has shown that LDL, at physiological concentrations, interacts with polymorphonuclear neutrophil stimulation either directly by its own stimulating effect or indirectly by modification of the response to formylMet-Leu-Phe.
In previous work (5), a slight enhancement of the binding of formyl-Met-Leu-Phe to its specific membrane receptors was observed in the presence of LDL which may induce an increase in Oi~ released in response to formyl-Met-Leu-Phe. Because LDL did not interfere with pertussis toxin inhibitable G proteins, they also might have a "priming" effect which can potentiate the NADPH oxidase stimulation by formyl-Met-Leu-Phe (34) rather than increase the number or affinity of the formyl-Met-Leu-Phe receptors.
Phospholipase C activity was investigated by means of inositol phosphate measurement and a phosphoinositide metabolism study. We observed a highly significant increase of phosphatidylinositol 4,5-bisphosphate content which could not be due to an accelerated inositol turnover because dephosphorylating enzymes were inhibited by the lithium added to the incubation buffer. However, it is possible that tritiated inositol, in excess in the cell medium, conjugated to CMP-activated phosphatidic acid was able to replenish membrane stocks of phosphatidyl inositol (phosphates). This phenomenon might be due to phospholipase D activation by LDL, leading to an increased generation of phosphatidic acid. This activation may be greater than that of phospholipase C inducing a relatively weak enhancement of inositol 1,4,5-trisphosphate release. Inositol 1,4,5-trisphos-. phate is released into the cytosol, binds to specific receptors on intracellular Ca 2+ storage organelles and induces the release of calcium. In our study, the intracellular calcium mobilization, measured as Fura 2 fluorescence intensity, increased with LDL concentrations. However at LDL cholesterol concentrations above 0.5 mmo/1, Fura 2 fluorescence was sustained even in an incubation medium without calcium and in the presence of EGTA (data not shown). These data suggest that the calcium efflux could be decreased by LDL. To the best of our knowledge, there is no previous study on the effect of LDL on polymorphonuclear neutrophil phosphoinositide metabolism. However Block et al. (35) have already described a stimulation of the phosphatidylinositol cycle by LDL in human platelets, lymphocytes and fibroblasts.
Protein kinase C, a phospholipid/Ca 2+ -dependent kinase, is a key enzyme in the regulation of intracellular signal transduction. Staurosporine, an alkaloid extracted from Streptomyces, was described by Tamaoki et al. (36) as a protein kinase C inhibitor. These authors have suggested that Staurosporine interacts directly with protein kinase C and this hypothesis has been corroborated by Nakadate et al. (37) who have shown that Staurosporine interacts at the active site of the catalytic fragment of protein kinase C. Staurosporine is one of the most potent inhibitors, active at nanomolar concentrations, but demonstrates similar affinities for protein kinase C, tyrosine kinases and c-AMP-dependent protein kinase (38, 39) . In our previous experiments, polymorphonuclear neutrophil stimulation by phorbol myristate acetate was inhibited 90% by Staurosporine, 100 nmol/1. However, the effect of LDL on polymorphonuclear neutrophil does not seem to be directly and exclusively protein kinase C-dependent because in the present study it was not inhibited by staurosporine.
Nevertheless, staurosporine exerts several effects on polymorphonuclear neutrophil activation. This substance at a concentration of 100 nmol/1 potentiates polymorphonuclear neutrophil stimulation by formyl-MetLeu-Phe (40) and inhibits Superoxide generation at higher concentrations. These effects might depend on the length of polymorphonuclear neutrophil treatment with staurosporine. Combadiere et al. reported 125% O 2~ production compared to the control (41) while we found a 200% increase in O 2~ production by polymorphonuclear neutrophil incubation 10 min with staurosporine before the addition of formyl-Met-Leu-Phe. Likewise, an increase of phosphatidic acid release was shown by Reinhold et al. (42) and Perianin et al. (43) . Recently, Mori et al. (44) have shown that enhancement of Superoxide production by staurosporine 100 nmol/1 via phospholipase D activation in formyl-Met-Leu-Phestimulated polymorphonuclear neutrophils was the result of an increase in diacylglycerol production through phosphatidic acid.
Considering the phopsholipase D activation already described with staurosporine, we hypothesize that the effects of LDL treatment on polymorphonuclear neutrophil phosphoinositide metabolism could be explained by a similar mechanism.
In formyl-Met-Leu-Phe-activated polymorphonuclear neutrophils, phosphatidylcholine is the phospholipase D substrate generating phosphatidic acid which in turn leads to a diacylglycerol release after its dephosphorylation by phosphatidate phosphohydrolase. Rossi et al. have shown that this enzyme was inhibited by propranolol (45) . In the same experimental conditions as those used by these authors, we showed an enhancement of O 2~ generation which is for English et al. (46) correlated to phosphatidic acid release. However, Agwu et al. have shown that polymorphonuclear neutrophil stimulation by formyl-MetLeu-Phe was counteracted by high a propranolol concentration (5 mmol/1) which inhibited phospholipase D (47) . Under the same experimental conditions, we observed that LDL did not modify the propranolol effect.
In formyl-Met-Leu-Phe-stimulated human neutrophils, protein kinase C-independent activation mechanisms have been suggested and M ller & Nigam (48) have shown that staurosporine enhances arachidonic acid and platelet activation, and leukotriene B 4 release. We have thus tested the activity of niflumic acid, a non-steroidal anti-inflammatory drug, on polymorphonuclear neutrophil activation. According to Abramson et al. (49) various concentrations of niflumic acid inhibited formylMet-Leu-Phe-induced O 2~ generation in a concentrationdependent manner. Nevertheless, niflumic acid did not inhibit the LDL-induced polymorphonuclear neutrophil oxidative metabolism and even the lowest concentration used (88.5 μπιοΙ/1) potentiated an LDL effect, probably by stimulating phospholipase A 2 , which leads to arachidonic acid accumulation.
LDL is able to modify in vitro the polymorphonuclear neutrophil oxidative metabolism either by a direct stimulating effect or by alteration of the polymorphonuclear neutrophil response to formyl-Met-Leu-Phe by an action which could involve phospholipase D and phospholipase A 2 activations.
The LDL structure plays a main role in its action of polymorphonuclear neutrophil functions. LDL modifies cell lipid content, since a concentration-dependent increase in cholesterol level was observed after incubation of polymorphonuclear neutrophil with increasing LDL concentrations. We have previously demonstrated (5) that LDL from hypertriglyceridaemic subjects stimulated the polymorphonuclear neutrophil oxidative metabolism and inhibited polymorphonuclear neutrophil chemotaxis less than LDL from normolipaemic subjects whose composition is different. Moreover, LDL trypsination experiments showed that the lipid moiety is mainly responsible for the described effects of LDL on polymorphonuclear neutrophil migration (5). These observations, added to the fact that the polymorphonuclear neutrophil cholesterol amount increases after the incubation of these cells with increasing LDL concentrations, suggest that lipid exchanges between lipoproteins and cell membranes might appear and modify the membrane fluidity. These modifications could alter formyl-MetLeu-Phe receptor expression and affinity. This hypothesis was corroborated upon viewing the alteration of formyl-Met-Leu-Phe binding on polymorphonuclear neutrophils extracted from hyperlipidaemic type lib patients (50) .
In spite of their short half-life, polymorphonuclear neutrophils could be involved in atherogenic states because they display, in their excited state, a great source of free radicals involved in endothelial injuries. LDL are transported into the intimal layer through the endothelium (51) and their concentration in the arterial intima is three times greater than in plasma (52) . The polymorphonuclear neutrophils present in the intima may be activated by LDL. Activated neutrophils might produce oxygen free radicals and therefore modify LDL but they are found in small numbers in the atherosclerotic intima (53) . However it has been shown in rabbits fed a high cholesterol diet that polymorphonuclear neutrophils were the most numerous cells at the beginning of the atheromateous process, and were soon replaced by monocytes and lymphocytes (54) . Therefore it seems particularly interesting to study the interaction between polymorphonuclear neutrophils and lipoproteins during the early stages of atherogenesis in animal models.
